Pinwheel Therapeutics raises $20mn from 108 BioCapital EP News Bureau Feb 5, 2026 Funding linked to late-stage clinical asset transaction
Lupin launches Topiramate Extended-Release Capsules in the US EP News Bureau Feb 5, 2026 Launch follows FDA approval for ANDA
Zydus receives USFDA tentative approval for dapagliflozin tablets EP News Bureau Feb 4, 2026 Approval covers 5 mg and 10 mg strengths for US market
Sun Pharma named principal sponsor and health partner of Royal Challengers Bengaluru EP News Bureau Feb 4, 2026 Three-year partnership marks Sun Pharma’s first cricket sponsorship
CDSCO approves durvalumab with FLOT for resectable gastric and GEJ cancer in India EP News Bureau Feb 4, 2026 Approval based on phase III MATTERHORN study supports perioperative use
UP Pharma Conclave 1.0 inaugurated in Lucknow; Gov outlines investment and manufacturing roadmap EP News Bureau Feb 4, 2026 CM Yogi Adityanath sets out policy framework, law and order measures, and pharma sector plans at investor congregation
Friendshoring: Pharma’s next supply chain bet? Neha Aathavale Feb 4, 2026 With friendshoring gaining attention in global supply chain conversations, this story looks at what it could mean for the India…
Lupin launches Dasatinib tablets in United States EP News Bureau Feb 3, 2026 Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following…
Express Pharma February 2026 EP News Bureau Feb 3, 2026 India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Supply Chain Bet?
SPARC receives Priority Review Voucher associated with Sezaby approval EP News Bureau Feb 3, 2026 Sun Pharma Advanced Research Company (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a…